Zynerba Jumps on Fast Track Designation Approval
The company has received fast track designation for its lead candidate, Zygel, which aims to treat...
May 6th, 2019
BBHIC 2019, Day 2: Notes From the Floor
The second day of the show had more company presentations, interviews and a panel discussion on...
May 1st, 2019
BBHIC 2019, Day 1: Notes from the Floor
For INN, day one was full of company presentations, interviews and a panel discussion on commercial-stage...
April 30th, 2019
5 Top Weekly NASDAQ Biotech Stocks: Aratana Soars on...
Last week's other top NASDAQ biotech stocks were X4 Pharmaceuticals, Zynerba Pharmaceuticals, Vaccinex and Marinus Pharmaceuticals.
April 28th, 2019
Pharma Market Update: Q1 2019 in Review
With Q1 2019 officially over, the Investing News Network shares a pharma market update on the...
April 18th, 2019
5 Top Weekly NASDAQ Biotech Stocks: PhaseBio Gets Breakthrough...
Vital Therapies, Precipio, Chimerix, ContraFect and PhaseBio Pharmaceuticals were last week's top gainers.
April 14th, 2019
5 Top Pharma Stocks on the TSX Year-to-Date
With the first quarter of 2019 over, it's time to look back on the top performing...
April 10th, 2019